A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV (NCT06564194)
A Phase 1 Randomized, Double-Blinded Study to Assess the Safety, Reactogenicity and Immunogenicity of JCXH-108, an mRNA-based Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Healthy Subjects ≥ 60 Years of Age and 18-45 Years of Age
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to assess the safety, reactogenicity and immunogenicity of an mRNA-based vaccine, JCXH-108, the prevention of Respiratory Syncytial Virus (RSV) infection and diseases. Participants will be randomized to receive either JCXH-108 or placebo.
Who can join: Review the eligibility criteria below.
Location: Health Awareness — Jupiter, Florida
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Health Awareness — Jupiter, Florida
- DelRicht - New Orleans — New Orleans, Louisiana
- Sundance Clinical Research — St Louis, Missouri
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Respiratory Syncytial Virus (RSV)
- Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos — New York, New York
- Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants — New York, New York
- Systems Biological Analysis of Immune Responses to RSV Vaccine — Decatur, Georgia
- A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults — Rochester, New York
- RSV Vaccine Pregnancy Registry — Wilmington, North Carolina
Explore by condition: All Respiratory Syncytial Virus (RSV) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.